n-methylscopolamine has been researched along with verapamil in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (25.00) | 18.7374 |
1990's | 3 (37.50) | 18.2507 |
2000's | 2 (25.00) | 29.6817 |
2010's | 1 (12.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Arita, Y; Kimura, T; Nawata, H; Ogami, Y; Yazu, T | 1 |
Brann, MR; Ellis, J; Huyler, J | 1 |
el-Fakahany, EE; Lee, NH | 1 |
Ellis, J; Seidenberg, M | 1 |
Christophe, J; De Neef, P; Robberecht, P; Waelbroeck, M | 1 |
Fujino Oki, T; Kato, Y; Kurosawa, S; Nanri, M; Uchida, S; Yamada, S; Yoshida, K | 1 |
8 other study(ies) available for n-methylscopolamine and verapamil
Article | Year |
---|---|
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.
Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship | 2009 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Effects of calcium-channel blockers on cytosolic free calcium and amylase secretion in rat pancreatic acini.
Topics: Amylases; Animals; Bombesin; Calcium; Calcium Channel Blockers; Carbachol; Ceruletide; Cytosol; Diltiazem; In Vitro Techniques; Male; N-Methylscopolamine; Pancreas; Peptide Fragments; Rats; Rats, Inbred Strains; Scopolamine Derivatives; Verapamil | 1991 |
Allosteric regulation of cloned m1-m5 muscarinic receptor subtypes.
Topics: Animals; Binding Sites; Cell Line; Gallamine Triethiodide; Humans; Kinetics; N-Methylscopolamine; Quinuclidinyl Benzilate; Rats; Receptors, Muscarinic; Scopolamine Derivatives; Tubocurarine; Verapamil | 1991 |
Allosteric interactions at the m1, m2 and m3 muscarinic receptor subtypes.
Topics: Allosteric Regulation; Animals; Cells, Cultured; Cricetinae; Gallamine Triethiodide; N-Methylscopolamine; Parasympatholytics; Pertussis Toxin; Phenethylamines; Potassium Channels; Rats; Rats, Inbred Strains; Receptors, Muscarinic; Scopolamine Derivatives; Verapamil; Virulence Factors, Bordetella | 1991 |
Interactions between gallamine and muscarinic receptors: allosterism and subpopulation specificity are separate phenomena.
Topics: Animals; Brain Stem; Gallamine Triethiodide; In Vitro Techniques; Male; Molecular Conformation; N-Methylscopolamine; Quinuclidinyl Benzilate; Rats; Rats, Inbred Strains; Receptors, Muscarinic; Scopolamine Derivatives; Verapamil | 1987 |
Effects of verapamil on the binding properties of rat heart muscarinic receptors: evidence for an allosteric site.
Topics: Allosteric Site; Animals; Binding, Competitive; Kinetics; Myocardium; N-Methylscopolamine; Oxotremorine; Rats; Receptors, Muscarinic; Scopolamine Derivatives; Verapamil | 1984 |
Binding activities by propiverine and its N-oxide metabolites of L-type calcium channel antagonist receptors in the rat bladder and brain.
Topics: Analysis of Variance; Animals; Benzilates; Brain; Calcium Channels, L-Type; Diltiazem; Isradipine; Male; Mandelic Acids; N-Methylscopolamine; Protein Binding; Rats; Rats, Sprague-Dawley; Tritium; Urinary Bladder; Verapamil | 2007 |